Citation Impact
Citing Papers
Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2014
Breast cancer
2019 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Aromatase Inhibitors in Breast Cancer
2003
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
2015
Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
2014
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Anthrazykline in der Krebstherapie
1997 Standout
The tumor microenvironment
2020 Standout
Clinical potential of new antiestrogens.
1997
Historical perspective on hormonal therapy of advanced breast cancer
2002
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Gene signatures of breast cancer progression and metastasis
2011
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer
2000
Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms
2009
Immunity, Inflammation, and Cancer
2010 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Epirubicin
1997
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001
2011
Adipocytes in the Tumour Microenvironment
2020
Management of malignant pleural effusions
2001 Standout
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Drug discovery from medicinal plants
2005 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF
2017
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials
2004
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Endocrine treatment options for advanced breast cancer – the role of fulvestrant
2004
Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective
2004
Fluorine in medicinal chemistry
2007 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection
2007
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Estrogen Receptors as Therapeutic Targets in Breast Cancer
2008
The landscape of metastatic progression patterns across major human cancers
2014
Metastasis-Initiating Cells and Ecosystems
2021
Moyamoya following cranial irradiation for primary brain tumors in children
2007
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
RMAF: Relu-Memristor-Like Activation Function for Deep Learning
2020
Basic Guide to the Mechanisms of Antiestrogen Action
1998
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Colorectal cancer statistics, 2017
2017 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Activation functions in deep learning: A comprehensive survey and benchmark
2022 Standout
Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
2011
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States
2016
Deep Reinforcement Learning Assisted Federated Learning Algorithm for Data Management of IIoT
2021 Standout
Works of Lars Stenbygaard being referenced
Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group
2011
Effect Of Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf) On Hematologic Toxicity Induced By High-Dose Chemotherapy In Patients With Metastatic Breast Cancer
1995
Toremifene and tamoxifen in advanced breast cancer - a double-blind cross-over trial
1993
Post-mastectomy radiotherapy in Denmark: From 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group
2008
Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group
2013
Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer
1999
Elevated Alpha-Feto Protein in a 51-Year-old Male with Relapsing Seminoma, Previous Hepatitis B and Acute Hepatitis C
1995
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
2010
Metastatic Pattern at Autopsy in non-resectable Adenocarcinoma of the Lung:A Study from a Cohort of 259 Consecutive Patients Treated with Chemotherapy
1997